X
 
Based in Malaysia, Bioven is an international company with offices in Kuala Lumpur and London.
 
OUR STORY OUR TEAM
BOARD OF DIRECTORS
Tan Sri Dato' Dr. Abu Bakar Suleiman
Chairman

A consultant nephrologist, Dr Abu Bakar was previously the Director-General of the MoH, Malaysia and appointed as the President of a leading private university, International Medical University (IMU), in 1991. in 2011, Dr Abu Bakar brings a wealth of experience and knowledge in Public Healthcare as well as a commercial healthcare provider. He was appointed Chairman of Integrated Healthcare Holdings Ltd (IHH), the 2nd largest private healthcare group in the world, in 2011.

Dr Abu Bakar has been Bioven’s Chairman since 2009.

Johan Indot
Executive Deputy Chairman

Johan is the founder and major shareholder in Bioven, incorporated in 2002. Johan is an entrepreneur and has developed many start up companies that have eventually been sold on. He currently has investment interest in Oil and Gas and Finance and took on an active role in Bioven in 2006.

Johan has worked closely with the management team to develop Bioven’s assets.

Naser Jaafar
Director

Naser Jaafar is the Chief Operating Officer at Agensi Inovasi Malaysia (AIM). His team is responsible for creating wealth through innovation via strategic equity investment in game changing and high impact innovative start-ups and commercialization of innovations from public and private universities and research institutes as well as from the industry.

Prior to joining AIM, Naser was with Bank of America Merrill Lynch Malaysia for 22 years, of which from 2002 to 2012, as the Chief Executive Officer. Naser has served various positions at the Bank in Malaysia, Singapore and Jakarta. Naser received his Masters of Business Administration from North Texas State University, USA in 1987.

Naser joined the Board in April 2015.

Wong Mun Keong
Director

Mun Keong was the General Manager, Business Development and Corporate Finance, at a Malaysian listed group in property and infrastructure development. Mun Keong is a former lecturer in finance at the University of Technology, Sydney, and headed the KL office of Schroder Research (Malaysia). He is currently Chief Investment Officer at Private Investment Company, managing over USD200m in assets with investments in property development, manufacturing and mining.

MANAGEMENT TEAM
Johan Indot
Executive Deputy Chairman

Johan is the founder and major shareholder in Bioven, incorporated in 2002. Johan is an entrepreneur and has developed many start up companies that have eventually been sold on. He currently has investment interest in Oil and Gas and Finance and took on an active role in Bioven in 2006.

Johan has worked closely with the management team to develop Bioven’s assets.

Dr Erik D’Hondt
CSO

Erik D’Hondt joined Bioven in 2009 as Head of R&D and Regulatory. Erik is a highly experienced drug development executive who worked for 28 years at SmithKline Beecham (now GlaxoSmithKline) in biologicals research and regulatory roles. More recently, Erik was Vice-President of Therapeutics at Europe’s Innogenetics (now Fujirebio Europe) and he has also consulted widely in Asia for institutes and biotechnology companies. He was an adviser to the World Health Organisation on preparedness for pandemic influenza.

Dr Lesley Pillans
Medical Liaison & Eudravigilence

Lesley is a Special Grade Doctor in Eating Disorders and practises in Aberdeen, Scotland. Prior to joining Bioven as Head of Medical Liaison, where she is responsible for Eudravigilence, medical affairs and communications, Lesley had worked as Medical Advisor for Shell International BV at the Hague. She has also worked in Malaysia as a Clinical Research Officer at University Malaya Medical Centre in Kuala Lumpur.

Hilary Cheong
Head - Operations

Hilary is a qualified pharmacist cum pharmacologist with more than 15 years experiences in global biopharmaceuticals and life sciences corporates, in charge of cross functional roles in regional business development, product lifecycle management, medical and clinical affairs, and market access/ commercialisation.

Shirley Chong
Financial Controller

Shirley graduated with a Bachelor of Accounting (Hons) from Multimedia University Cyberjaya. Started her career with KPMG as Tax Consultant for 6 years. She then moved to the commercial from various industries ( IT, Training and healthcare supplies and trading) as Finance Manager. She joined Bioven in April 2016 as Financial Controller.